Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur L Reingold

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
JAMA|April 13, 2006
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccineKatherine A Poehling, Thomas R Talbot, Marie R Griffin, et al.
BMJ Open|August 31, 2017
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USARuth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
Plos One|March 9, 2022
Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017Stephanie A Kujawski, Michael Whitaker, Matthew D Ritchey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2020
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)Lindsay Kim, Shikha Garg, Alissa O'Halloran, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
JAMA|April 13, 2006
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccineKatherine A Poehling, Thomas R Talbot, Marie R Griffin, et al.
BMJ Open|August 31, 2017
Generalisability of vaccine effectiveness estimates: an analysis of cases included in a postlicensure evaluation of 13-valent pneumococcal conjugate vaccine in the USARuth Link-Gelles, Daniel Westreich, Allison E Aiello, et al.
Plos One|March 9, 2022
Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017Stephanie A Kujawski, Michael Whitaker, Matthew D Ritchey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2020
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)Lindsay Kim, Shikha Garg, Alissa O'Halloran, et al.
Pageof 7